Monte Rosa Therapeutics, Inc. GLUE Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported operating lease right-of-use assets in other assets of $24.69M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 6.0% year-over-year, from $26.26M to $24.69M.